Business Context and Reporting Period
This Form 8-K Current Report from Nephros, Inc. covers events occurring on January 4, 2015, with the report filed on January 7, 2015. The filing primarily addresses significant changes in corporate leadership and governance.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Departure of CEO: John C. Houghton separated from employment as President, Chief Executive Officer, and Acting Chief Financial Officer effective January 4, 2015. He also resigned from the Board of Directors.
- Reason for Departure: The resignation was not due to any disagreement with the Company regarding operations, policies, or practices.
- Severance Terms: Mr. Houghton is entitled to six months of severance and a 90-day window to exercise vested unexpired stock options. He is subject to non-competition, non-solicitation, and confidentiality restrictions during the severance term.
- Appointments: Paul A. Mieyal, a current Board member, was appointed Acting President, Acting CEO, Acting CFO, and Acting Secretary. Dr. Mieyal will serve in these capacities without employee compensation or benefits during this interim period.
- Board Leadership: Daron Evans was appointed Chairman of the Board and will continue to serve as Chairman of the Audit Committee.
Outlook, Risks, and Management Commentary
The filing includes a press release (Exhibit 99.1) regarding the leadership transition. No specific financial guidance, future outlook, or new risk factors were disclosed in this text. The appointment of Dr. Mieyal, who previously served as Acting CEO from 2010 to 2012, suggests a reliance on existing board knowledge during the interim period.
Investor Verification Checklist
- Verify the terms of the Separation Agreement and General Release with John C. Houghton to confirm the exact severance cost and any potential litigation risks.
- Confirm the timeline for the search for a permanent Chief Executive Officer and Chief Financial Officer.
- Review the Company's cash position to ensure it can sustain operations under interim leadership without immediate new financing.
- Check for any subsequent filings regarding the status of Mr. Houghton's stock option exercises.